Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of Belotecan monotherapy in patients with recurrent or persistent cervical cancer
KCT0004484Phase 2Recruiting
- Sponsor
- Chong Kun Dang
- Start
- Sep 2020
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of belotecan in Cervical Cancer (CC), sponsored by Chong Kun Dang. Started Sep 2020; status: recruiting.
02
Drugs
belotecan
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on KCT0004484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004484.